ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $34.58 million. The enterprise value is -$27.83 million.

Market Cap	34.58M
Enterprise Value	-27.83M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ALXO has 53.44 million shares outstanding. The number of shares has increased by 11.80% in one year.

Current Share Class	53.44M
Shares Outstanding	53.44M
Shares Change (YoY)	+11.80%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	2.47%
Owned by Institutions (%)	33.51%
Float	31.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.25.

Current Ratio	4.52
Quick Ratio	4.24
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-70.35

Financial Efficiency

Return on equity (ROE) is -104.21% and return on invested capital (ROIC) is -57.54%.

Return on Equity (ROE)	-104.21%
Return on Assets (ROA)	-47.78%
Return on Invested Capital (ROIC)	-57.54%
Return on Capital Employed (ROCE)	-154.92%
Revenue Per Employee	n/a
Profits Per Employee	-$1.46M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.79% in the last 52 weeks. The beta is 1.14, so ALXO's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-73.79%
50-Day Moving Average	0.53
200-Day Moving Average	0.96
Relative Strength Index (RSI)	60.14
Average Volume (20 Days)	577,563

Short Selling Information

The latest short interest is 4.48 million, so 8.37% of the outstanding shares have been sold short.

Short Interest	4.48M
Short Previous Month	4.39M
Short % of Shares Out	8.37%
Short % of Float	14.28%
Short Ratio (days to cover)	8.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-118.47M
Pretax Income	-166.20M
Net Income	-116.57M
EBITDA	-117.63M
EBIT	-118.47M
Earnings Per Share (EPS)	-$2.17

Balance Sheet

The company has $79.31 million in cash and $16.18 million in debt, giving a net cash position of $63.13 million or $1.18 per share.

Cash & Cash Equivalents	79.31M
Total Debt	16.18M
Net Cash	63.13M
Net Cash Per Share	$1.18
Equity (Book Value)	64.42M
Book Value Per Share	1.20
Working Capital	66.41M

Cash Flow

In the last 12 months, operating cash flow was -$105.49 million and capital expenditures -$316,000, giving a free cash flow of -$105.81 million.

Operating Cash Flow	-105.49M
Capital Expenditures	-316,000
Free Cash Flow	-105.81M
FCF Per Share	-$1.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.80%
Shareholder Yield	-11.80%
Earnings Yield	-330.19%
FCF Yield	-299.69%

Analyst Forecast

The average price target for ALXO is $3.30, which is 410.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.30
Price Target Difference	410.05%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3